Cervical cancer in north-eastern Libya: 2000-2008.

Area of Science:

• Oncology
• Gynecologic Oncology
• Public Health

Background:

• Cervical cancer remains a significant health concern globally.
• Libya, within the EMRO region, faces unique challenges in cancer care.
• Understanding the epidemiology of cervical cancer in Libya is vital for targeted interventions.

Purpose of the Study:

• To analyze the epidemiological and clinical characteristics of cervical cancer patients in Libya.
• To identify key challenges in cervical cancer diagnosis and treatment in the region.
• To provide data-driven recommendations for improving cervical cancer control in Libya.

Main Methods:

• Retrospective analysis of patient records from a primary oncology clinic in Libya over 9 years.
• Inclusion of 74 Libyan cervical cancer patients.
• Data collection on patient demographics, cancer stage, histology, HPV status, diagnostic methods, and treatment modalities.

Main Results:

• Cervical cancer constituted 1.8% of female cancers (n=74).
• Average age of presentation was 53, with 60% premenopausal. 65% diagnosed at late stages (III-IV).
• Squamous cell carcinoma (83.8%) was predominant, often diagnosed at later stages. HPV-16 (82.5%) and HPV-18 (12.7%) were highly prevalent. Diagnosis primarily via biopsy (97.3%). Chemotherapy (75%) and triple therapy (38%) were common treatments.

Conclusions:

• Delayed presentation and late-stage diagnosis are major issues for cervical cancer in Libya.
• High HPV prevalence underscores the need for vaccination and screening.
• Recommendations include enhanced public awareness, a national cancer control plan, and a national screening program.